Published in
Wiley Open Access, Cancer Medicine, 17(10), p. 5839-5846, 2021
DOI: 10.1002/cam4.4130
Links
Tools
Outcomes of axitinib versus sunitinib as first‐line therapy to patients with metastatic renal cell carcinoma in the immune‐oncology era
Journal article published in 2021 by
Kazuyuki Numakura 
,
Yumin Muto,
Sei Naito,
Shingo Hatakeyama,
Renpei Kato ,
Tomoyuki Koguchi,
Takahiro Kojima,
Yoshihide Kawasaki,
Syuya Kandori ,
Sadafumi Kawamura,
Yoichi Arai,
Akihiro Ito,
Hiroyuki Nishiyama,
Yoshiyuki Kojima,
Wataru Obara
and other authors.
,
Yumin Muto,
Sei Naito,
Shingo Hatakeyama,
Renpei Kato ,
Tomoyuki Koguchi,
Takahiro Kojima,
Yoshihide Kawasaki,
Syuya Kandori ,
Sadafumi Kawamura,
Yoichi Arai,
Akihiro Ito,
Hiroyuki Nishiyama,
Yoshiyuki Kojima,
Wataru Obara
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 